- Correction of F8 intron 1 inversion in hemophilia A patient-specific iPSCs by CRISPR/Cas9 mediated gene editing.
Correction of F8 intron 1 inversion in hemophilia A patient-specific iPSCs by CRISPR/Cas9 mediated gene editing.
Frontiers in Genetics (2023)
Hu, et al.
PMID36968612
MATERIALS
Product Number
Brand
Product Description
Sigma-Aldrich
Monoclonal Anti-α-Fetoprotein (AFP) antibody produced in mouse, ascites fluid, clone C3